Pediatric hospitals are beginning to use generative AI for documentation, care coordination, and workflow support, with near-term value in reducing...

1. The Joint Commission has launched a voluntary certification program focused on responsible artificial intelligence use in healthcare organizations. 2....

1. The Food and Drug Administration is reviewing an artificial intelligence based tool that could help predict drug induced liver...

Food and Drug Administration reviews artificial intelligence tool for liver injury prediction The Food and Drug Administration (FDA) is reviewing...

1. Gilead reported positive phase 3 IDEAL data for seladelpar (Livdelzi) in patients with primary biliary cholangitis who had persistent...

1. The European Commission has authorized expanded venetoclax (Venclyxto) combinations for previously untreated chronic lymphocytic leukemia. 2. The approval reinforces...

1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural...

1. Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 billion in...

Pfizer and Innovent deepen the China biotech licensing wave Pfizer is making another large oncology bet, this time through a...

Caloric restriction and intermittent fasting show mixed human longevity data Caloric restriction remains one of the most robust interventions for...